Development and optimization of MicroRNA against relaxin-3

GE Callander; WG Thomas; RAD Bathgate

Conference Proceedings

Development and optimization of MicroRNA against relaxin-3

GE Callander, WG Thomas, RAD Bathgate

Annals of the New York Academy of Sciences | WILEY-BLACKWELL | Published : 2009

DOI: 10.1111/j.1749-6632.2008.03816.x

Abstract

Recent in vivo studies suggest a role for relaxin-3 in feeding and stress. To further elucidate the function of relaxin-3 in the central nervous system, we have employed a complementary approach, based on RNA interference, to modulate relaxin-3 expression. We have designed, constructed, and characterized three microRNAs (miRNAs) targeting different regions of the relaxin-3 transcript. These were tested to determine the amount of miRNA required to achieve the greatest knockdown and for their ability to reduce the expression of relaxin-3 in transfected HEK293Tcells. All miRNA constructs significantly reduced relaxin-3-induced cAMP responses; however, miR499 was most effective. This should be a..

View full abstract

University of Melbourne Researchers

Ross Bathgate Author

Related Projects (3)

Novel G-protein coupled receptors LGR7 and LGR8; the receptors for relaxin and insulin-like peptide 3 (INSL3)

Relaxin is a hormone which has long been known to have essential roles in pregnancy and birth. However it has also been demonstrated to have..

Relaxin Family Peptide Receptors

Relaxin is a hormone which has long been known to have essential roles in pregnancy and birth. However it has also been demonstrated to have..

NHMRC RESEARCH FELLOWSHIP 2008 - BATHGATE

I am a molecular endocrinologist determining the mechanisms by which relaxin family peptides bind to and activate their receptors and induce..

Grants

Awarded by National Health and Medical Research Council of Australia

Funding Acknowledgements

Dr. Ross Bathgate and Prof. Walter Thomas are recipients of fellowships from the National Health and Medical Research Council of Australia (509011 and 317814). Gabrielle Callander is a recipient of a Melbourne Research Scholarship. This work was supported by project grants 300012 and 454375 (RADB) and 418921 (WGT) from the National Health and Medical Research Council of Australia.